Securing America’s Drug Supply from Communist China Act

[Congressional Bills 119th Congress] [From the U.S. Government Publishing Office] [S. 4327 Introduced in Senate (IS)] <DOC> 119th CONGRESS 2d Session S. 4327 To require regulatory review of pharmaceutical products from Chinese entities, and for other purposes. _______________________________________________________________________ IN THE SENATE OF THE UNITED STATES April 16 (legislative day, April 14), 2026 Mr. Cotton introduced the following bill; which was read twice and referred to the Committee on Health, Education, Labor, and Pensions _______________________________________________________________________ A BILL To require regulatory review of pharmaceutical products from Chinese entities, and for other purposes. Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled, SECTION 1. SHORT TITLE. This Act may be cited as the ``Securing America's Drug Supply from Communist China Act''. SEC. 2. REGULATORY REVIEW OF PHARMACEUTICAL PRODUCTS FROM CHINESE ENTITIES. (a) Definitions.--In this section: (1) Chinese entity.--The term ``Chinese entity'' means an entity organized under the laws of the People's Republic of China or otherwise subject to the jurisdiction of the Government of the People's Republic of China. (2) Drug application.--The term ``drug application'' means an application submitted under subsection (b) or (j) of section 505 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 355) or subsection (a) or (k) of section 351 of the Public Health Service Act (42 U.S.C. 262). (3) PRC-, ccp-, or pla-affiliated entity.-- (A) In general.--The term ``PRC-, CCP-, or PLA- affiliated entity'' means any entity that receives support directly or indirectly from the Government of the People's Republic of China, the Chinese Communist Party, or the People's Liberation Army, including-- (i) an entity owned or controlled by the Government of the People's Republic of China or an entity owned or controlled by such an entity;